Detail akcie Spinnaker Opp Rg online

Business Summary: Kanabo Group plc is a United Kingdom-based patient-focused provider of digital health services and specialist medicines. The Company’s principal activities are the distribution and development of cannabis derived medical and wellness products. The Company operates through two segments: Primary case and Secondary case. Primary case segment is involved in the telepharma services provided by GPS. Secondary case segment is involved in the distribution and development of cannabis-derived medical and wellness products. The Company is focused on the distribution of cannabis-derived products for medical patients, and non- tetrahydrocannabinol (THC) products for cannabidiol (CBD) consumers. It has conducted research and development (R&D) in order to develop cannabis extract formulas, medical-grade vaporizers and various non-smoking consumption solutions. Its clinical and validation activities, including safety and efficiency tests, are conducted in Israel.
Financial Summary: BRIEF: For the six months ended 30 June 2024, Kanabo Group PLC revenues increased 55% to L694K. Net loss increased 12% to L1.8M. Revenues reflect Secondary care segment increase from L54K to L280K, Primary care segment increase of 5% to L413K. Higher net loss reflects Other operating income/expense decrease of 94% to L38K (income).